Sesquient is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sedor Pharmaceuticals, Llc. The primary component is Fosphenytoin Sodium.
| Product ID | 80674-210_8fa2abc6-e2d1-4647-a090-ca2f83481f5f |
| NDC | 80674-210 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sesquient |
| Generic Name | Fosphenytoin Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | NDA / |
| Application Number | NDA210864 |
| Labeler Name | Sedor Pharmaceuticals, LLC |
| Substance Name | FOSPHENYTOIN SODIUM |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2021-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-5471 | CEREBYX | Fosphenytoin Sodium |
| 0069-5474 | CEREBYX | Fosphenytoin Sodium |
| 0069-6001 | CEREBYX | Fosphenytoin Sodium |
| 63323-403 | Fosphenytoin | FOSPHENYTOIN SODIUM |
| 0143-9782 | Fosphenytoin Sodium | Fosphenytoin Sodium |
| 0143-9788 | Fosphenytoin Sodium | Fosphenytoin Sodium |
| 0641-6136 | Fosphenytoin Sodium | Fosphenytoin Sodium |
| 0641-6137 | Fosphenytoin Sodium | Fosphenytoin Sodium |
| 64679-729 | FOSPHENYTOIN SODIUM | fosphenytoin sodium |
| 64679-730 | FOSPHENYTOIN SODIUM | fosphenytoin sodium |
| 65162-998 | Fosphenytoin Sodium | Fosphenytoin Sodium |